TECH
Price
$50.25
Change
-$0.53 (-1.04%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
8.03B
12 days until earnings call
VRTX
Price
$493.52
Change
+$1.05 (+0.21%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
126.6B
10 days until earnings call
Ad is loading...

TECH vs VRTX

Header iconTECH vs VRTX Comparison
Open Charts TECH vs VRTXBanner chart's image
Bio-Techne
Price$50.25
Change-$0.53 (-1.04%)
Volume$24.3K
Capitalization8.03B
Vertex Pharmaceuticals
Price$493.52
Change+$1.05 (+0.21%)
Volume$20.4K
Capitalization126.6B
TECH vs VRTX Comparison Chart
Loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TECH vs. VRTX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECH is a Buy and VRTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (TECH: $50.78 vs. VRTX: $492.47)
Brand notoriety: TECH and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TECH: 118% vs. VRTX: 91%
Market capitalization -- TECH: $8.03B vs. VRTX: $126.6B
TECH [@Biotechnology] is valued at $8.03B. VRTX’s [@Biotechnology] market capitalization is $126.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $276.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 2 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).

  • TECH’s FA Score: 2 green, 3 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than TECH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TECH’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 7 bullish TA indicator(s).

  • TECH’s TA Score: 5 bullish, 3 bearish.
  • VRTX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than TECH.

Price Growth

TECH (@Biotechnology) experienced а +5.57% price change this week, while VRTX (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

Reported Earning Dates

TECH is expected to report earnings on Aug 12, 2025.

VRTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($127B) has a higher market cap than TECH($8.03B). TECH has higher P/E ratio than VRTX: TECH (51.27) vs VRTX (32.76). VRTX YTD gains are higher at: 22.292 vs. TECH (-29.417). VRTX has higher annual earnings (EBITDA): 486M vs. TECH (307M). VRTX has more cash in the bank: 6.12B vs. TECH (178M). TECH has less debt than VRTX: TECH (395M) vs VRTX (1.75B). VRTX has higher revenues than TECH: VRTX (11B) vs TECH (1.2B).
TECHVRTXTECH / VRTX
Capitalization8.03B127B6%
EBITDA307M486M63%
Gain YTD-29.41722.292-132%
P/E Ratio51.2732.76156%
Revenue1.2B11B11%
Total Cash178M6.12B3%
Total Debt395M1.75B23%
FUNDAMENTALS RATINGS
TECH vs VRTX: Fundamental Ratings
TECH
VRTX
OUTLOOK RATING
1..100
1611
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
9215
SMR RATING
1..100
7890
PRICE GROWTH RATING
1..100
6546
P/E GROWTH RATING
1..100
3226
SEASONALITY SCORE
1..100
7548

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is significantly better than the same rating for VRTX (78). This means that TECH’s stock grew significantly faster than VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (15) in the Biotechnology industry is significantly better than the same rating for TECH (92). This means that VRTX’s stock grew significantly faster than TECH’s over the last 12 months.

TECH's SMR Rating (78) in the Biotechnology industry is in the same range as VRTX (90). This means that TECH’s stock grew similarly to VRTX’s over the last 12 months.

VRTX's Price Growth Rating (46) in the Biotechnology industry is in the same range as TECH (65). This means that VRTX’s stock grew similarly to TECH’s over the last 12 months.

VRTX's P/E Growth Rating (26) in the Biotechnology industry is in the same range as TECH (32). This means that VRTX’s stock grew similarly to TECH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TECHVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 5 days ago
72%
Bearish Trend 18 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
53%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
40%
View a ticker or compare two or three
Ad is loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SZNE34.000.85
+2.56%
Pacer CFRA-Stovall Eq WghtSeasnlRottnETF
FINX28.060.39
+1.41%
Global X FinTech ETF
FMAY45.250.63
+1.41%
FT Vest US Equity Buffer ETF May
LEGR48.220.50
+1.05%
First Trust Indxx Invtv Tnsctn&Prcs ETF
VPU170.000.17
+0.10%
Vanguard Utilities ETF

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with CCCC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+0.01%
CCCC - VRTX
39%
Loosely correlated
N/A
KRYS - VRTX
37%
Loosely correlated
+2.00%
STTK - VRTX
37%
Loosely correlated
-1.57%
REGN - VRTX
36%
Loosely correlated
+2.03%
TECH - VRTX
36%
Loosely correlated
+1.24%
More